Stock ALDX ALDEYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-14 EDT 		5-day change 1st Jan Change
3.73 USD -3.37% Intraday chart for Aldeyra Therapeutics, Inc. -3.37% +6.27%
06-13 Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease CI
05-08 Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study MT
d2a0b589077e88a1967d6be75955298.nlJoxGqPE-uxsX0j3gcDjTqZtKDJMwoTW54vzRY2Hj8.rh4NsBnpYp7Q9BNktUlEx2nAhMWjWDM-GO1a_3dhKGrRJRGLCfx7r_LlMA~c2107759a7539283216bf99f0a549b0b
  1. Stock Market
  2. Equities
  3. ALDX Stock
  4. Charts Aldeyra Therapeutics, Inc.
  5. News Chart